1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA...
In this episode, we tackle the recent papers in the New England Journal of Medicine on "Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma" and "Immunotherapy Combinations in Multiple
soundcloud.com